ADMA Biologics Inc. (ADMA)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

18.43

-0.79%

After-hours Dec 13, 2024, 07:49 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10	FY09	FY08	FY07
Revenue	258.21M	154.08M	80.94M	42.22M	29.35M	16.99M	22.76M	10.66M	7.18M	5.92M	3.07M	1.12M	-	-	-	-	-
Cost of Revenue	169.27M	118.81M	79.77M	61.29M	39.50M	42.19M	29.16M	6.36M	4.31M	3.74M	2.02M	669.06K	-	-	-	-	-
Gross Profit	88.94M	35.27M	1.17M	-19.07M	-10.16M	-25.21M	-6.40M	4.30M	2.87M	2.17M	1.04M	449.06K	-	-	-	-	-
Operating Income	21.63M	-39.37M	-58.37M	-64.91M	-41.42M	-60.29M	-39.31M	-17.33M	-15.51M	-16.02M	-15.04M	-7.91M	-26.46K	-20.53K	-20.01M	-24.89M	-29.69M
Interest Income	1.62M	44.83K	34.53K	288.13K	800.78K	195.40K	57.23K	50.32K	37.83K	14.22K	7.62K	20.92K	4.00	4.00	-	-	48.00
Pretax Income	-28.24M	-65.90M	-71.65M	-75.75M	-48.28M	-65.74M	-43.76M	-19.52M	-17.97M	-17.36M	-15.53M	-7.92M	-26.46K	-20.53K	-20.01M	-24.89M	-29.69M
Net Income	-28.24M	-85.18M	-84.45M	-87.61M	-57.05M	-65.74M	-43.76M	-19.52M	-17.97M	-16.81M	-15.53M	-7.30M	-26.46K	-20.53K	-20.01M	-24.89M	-29.69M
Selling & General & Admin	59.02M	52.46M	42.90M	35.05M	25.91M	22.50M	18.09M	8.49M	6.75M	4.82M	4.37M	3.14M	26.46K	20.53K	-	-	24.00K
Research & Development	3.30M	3.61M	3.65M	5.91M	2.34M	3.93M	6.23M	7.69M	7.02M	9.52M	9.30M	3.47M	-	-	-	-	-
Other Expenses	4.99M	18.56M	13.00M	4.89M	3.01M	-127.12K	-10.14K	4.50K	4.62M	-74.36K	82.50K	1.75M	5.21K	3.03K	-20.01M	24.92M	29.73M
Operating Expenses	66.59M	74.63M	59.55M	45.84M	31.27M	35.08M	32.06M	21.63M	18.38M	18.19M	16.09M	8.36M	26.46K	20.53K	-20.01M	24.92M	29.73M
Interest Expense	25.03M	19.28M	13.06M	11.99M	8.99M	5.52M	3.29M	2.24M	1.84M	1.29M	618.23K	30.68K	-	-	-	-	-
Selling & Marketing Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost & Expenses	236.58M	193.44M	139.32M	107.13M	70.77M	77.27M	61.23M	27.99M	22.69M	21.93M	18.11M	9.03M	26.46K	20.53K	-20.01M	24.92M	29.73M
Income Tax	-	19.28M	12.81M	11.86M	8.77M	5.45M	4.45M	2.18M	2.46M	-551.72K	484.81K	-617.62K	-4	-4	-	-	-
Shares Outstanding (Basic)	223.98M	197.87M	139.58M	86.15M	54.35M	45.19M	22.90M	12.15M	10.41M	9.29M	6.53M	5.27M	2.50M	2.50M	2.50M	2.50M	2.50M
Shares Outstanding (Diluted)	223.98M	197.87M	139.58M	86.15M	54.35M	45.19M	22.90M	12.15M	10.41M	9.29M	6.53M	5.27M	2.50M	2.50M	2.50M	2.50M	2.50M
EPS (Basic)	-0.13	-0.43	-0.61	-1.02	-1.05	-1.45	-1.91	-1.61	-1.73	-1.81	-2.38	-1.39	-0.01	-0.01	-8	-9.96	-11.87
EPS (Diluted)	-0.13	-0.43	-0.61	-1.02	-1.05	-1.45	-1.91	-1.61	-1.73	-1.81	-2.38	-1.39	-0.01	-0.01	-8	-9.96	-11.87
EBITDA	5.12M	-39.72M	-53.33M	-59.82M	-36.03M	-56.77M	-39.31M	-16.81M	-15.66M	-15.83M	-14.70M	-7.71M	-4.40M	-5.02M	-20.01M	-24.89M	-29.69M
Depreciation & Amortization	8.33M	7.11M	5.50M	3.94M	3.26M	3.45M	1.23M	469.58K	469.82K	247.85K	210.63K	182.09K	4.00	4.00	-	-	-